Russell Investments Group
VTYX

Russell Investments Group’s Ventyx Biosciences VTYX Stock Holding History

Russell Investments Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,080
Closed -$36.8K – 4330
2025
Q4 		$36.8K Hold
4,080
– – ﹤0.01% 3409
2025
Q3 		$12.7K Hold
4,080
– – ﹤0.01% 3727
2025
Q2 		$8.73K Buy
4,080
+2,528
+163% +$4.08K ﹤0.01% 3357
2025
Q1 		$1.78K Buy
1,552
+1,262
+435% +$2.17K ﹤0.01% 3532
2024
Q4 		$635 Sell
290
-1,036
-78% -$2.35K ﹤0.01% 3578
2024
Q3 		$2.89K Sell
1,326
-7,166
-84% -$16.5K ﹤0.01% 3317
2024
Q2 		$19.6K Sell
8,492
-163
-2% -$677 ﹤0.01% 2941
2024
Q1 		$47.6K Buy
8,655
+580
+7% +$2.65K ﹤0.01% 2674
2023
Q4 		$19.9K Sell
8,075
-67,931
-89% -$645K ﹤0.01% 2745
2023
Q3 		$2.64M Buy
76,006
+28,459
+60% +$984K 0.01% 1393
2023
Q2 		$1.56M Sell
47,547
-29,406
-38% -$1.01M ﹤0.01% 1702
2023
Q1 		$2.58M Buy
76,953
+4,420
+6% +$172K 0.01% 1423
2022
Q4 		$2.38M Buy
+72,533
New +$2.15M ﹤0.01% 1478

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Russell Investments Group's VTYX Position: Q1 2026 in Review

Russell Investments Group sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 4,080 shares — an estimated $36.8K sold.

Russell Investments Group first reported a position in VTYX in Q4 2022 and held it in 13 quarters. The position peaked at $2.64M in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Russell Investments Group reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Russell Investments Group sold 4,080 Ventyx Biosciences shares in Q1 2026, an estimated $36.8K.
  • Russell Investments Group first reported a position in Ventyx Biosciences in Q4 2022 and held it in 13 quarters.
  • Russell Investments Group's Ventyx Biosciences position peaked at $2.64M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.